These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 1981306)
1. Overview. Purinergic mechanisms. Burnstock G Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306 [TBL] [Abstract][Full Text] [Related]
2. P1- and P2-purinoceptor subtypes--an update. Kennedy C Arch Int Pharmacodyn Ther; 1990; 303():30-50. PubMed ID: 2196860 [TBL] [Abstract][Full Text] [Related]
3. Subtypes of P2-purinoceptors. Studies using analogues of ATP. Cusack NJ; Hourani SM Ann N Y Acad Sci; 1990; 603():172-81. PubMed ID: 2291519 [TBL] [Abstract][Full Text] [Related]
4. Purinoceptors: are there families of P2X and P2Y purinoceptors? Abbracchio MP; Burnstock G Pharmacol Ther; 1994; 64(3):445-75. PubMed ID: 7724657 [TBL] [Abstract][Full Text] [Related]
5. Purinergic signalling: past, present and future. Burnstock G Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040 [TBL] [Abstract][Full Text] [Related]
6. Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens. Hoyle CH; Edwards GA Br J Pharmacol; 1992 Oct; 107(2):367-74. PubMed ID: 1422586 [TBL] [Abstract][Full Text] [Related]
10. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors. Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849 [TBL] [Abstract][Full Text] [Related]
11. Roles of P2-purinoceptors in the cardiovascular system. Ralevic V; Burnstock G Circulation; 1991 Jul; 84(1):1-14. PubMed ID: 1647896 [TBL] [Abstract][Full Text] [Related]
12. Current state of purinoceptor research. Burnstock G Pharm Acta Helv; 1995 Mar; 69(4):231-42. PubMed ID: 7651967 [TBL] [Abstract][Full Text] [Related]
13. Purinoceptors mediating relaxation and spasm in the rat gastric fundus. Matharu MS; Hollingsworth M Br J Pharmacol; 1992 Jun; 106(2):395-403. PubMed ID: 1393267 [TBL] [Abstract][Full Text] [Related]
14. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms. Rump LC; Oberhauser V; von Kügelgen I Kidney Int; 1998 Aug; 54(2):473-81. PubMed ID: 9690214 [TBL] [Abstract][Full Text] [Related]
15. Blood cells: an historical account of the roles of purinergic signalling. Burnstock G Purinergic Signal; 2015 Dec; 11(4):411-34. PubMed ID: 26260710 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological effects and metabolism of extracellular ATP]. Nakazawa M Nihon Yakurigaku Zasshi; 1991 Sep; 98(3):235-43. PubMed ID: 1743602 [TBL] [Abstract][Full Text] [Related]
17. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y. Palea S; Corsi M; Pietra C; Artibani W; Calpista A; Gaviraghi G; Trist DG J Pharmacol Exp Ther; 1994 Apr; 269(1):193-7. PubMed ID: 8169824 [TBL] [Abstract][Full Text] [Related]
19. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance. Verkhratsky A; Burnstock G Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352 [TBL] [Abstract][Full Text] [Related]